Tag: Pediatrics
-
Medical Student Investigates Sleep-Related Infant Deaths
Anna Briker, a second-year medical student, discusses her research investigating sleep-related risk factors in unexplained infant deaths in Cook County, which could be used to inform prevention programs.
-
Carvill Receives NIH New Innovator Award
Gemma Carvill, PhD, assistant professor of Neurology, has been named a recipient of the NIH Director’s New Innovator Award, which funds highly innovative research proposals with the potential to transform their field.
-
Northwestern Receives $12 Million Grant to Advance Epilepsy Research
Northwestern has been awarded a $12 million, five-year grant from the NIH for a research center dedicated to advancing the genetic understanding of epilepsy.
-
Reducing HIV Risk in Young Transgender Women
A behavioral program significantly reduced the sexual risk for HIV infection among young transgender women, according to a Northwestern Medicine clinical trial.
-
Prompt Treatment Improves Outcomes in Pediatric Sepsis
Pediatric patients with sepsis who completed a series of treatments within one hour of sepsis recognition had better outcomes, according to a new multi-center study.
-
Rethinking Longstanding Treatment for Diabetes Complications
Children with a rare complication of diabetes may not need fluid administered slowly, in contrast to current treatment guidelines, according to a study published in the New England Journal of Medicine.
-
Shilatifard Named Editor of Science Advances
Ali Shilatifard, PhD, has been appointed editor of Science Advances, an open-access journal published by the American Association for the Advancement of Science, which also publishes the journal Science.
-
Refining Standards of Maternal-Fetal Care
Novel research is changing the way we approach healthcare for mothers and their babies. Read the feature in Northwestern Medicine magazine.
-
Gene Therapy for Thalassemia Shows Promise
In new clinical trials, a gene therapy for a serious blood disorder called beta-thalassemia significantly improved outcomes among patients, without serious side effects.
-
Evaluating Pediatric Leukemia Treatment
A drug called dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a study published in the Journal of Clinical Oncology.
